DRESS syndrome medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 12: Line 12:
*The following drugs have been used in the management of DRESS syndrome:
*The following drugs have been used in the management of DRESS syndrome:
'''1. Symptomatic relief'''
'''1. Symptomatic relief'''
*''Pruritus'': Topical corticosteroids preferred over systemic steroids {{and}} antihistamines
*''Pruritus'': Topical [[corticosteroid]]s preferred over systemic steroids {{and}} [[antihistamine]]s
*''Fever'': [[Antipyretics|Antipyretic therapy]]
*''Fever'': [[Antipyretics|Antipyretic therapy]]
:*Note: Avoid antipyretic drugs that are cleared by the liver (e.g. acetaminophen) if liver injury is suspected and drugs cleared by the kidney (e.g. NSAIDs) if renal injury is suspected
:*Note: Avoid antipyretic drugs that are cleared by the liver (e.g. [[Acetaminophen]]) if liver injury is suspected and drugs cleared by the kidney (e.g. [[NSAID]]s) if renal injury is suspected
'''2. Exfoliative dermatitis'''
'''2. Exfoliative dermatitis'''
*Management of exfoliative dermatitis is similar to management of burns:<ref name="pmid10635613">{{cite journal| author=Roujeau JC| title=Treatment of severe drug eruptions. | journal=J Dermatol | year= 1999 | volume= 26 | issue= 11 | pages= 718-22 | pmid=10635613 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10635613  }} </ref>
*Management of exfoliative dermatitis is similar to management of burns:<ref name="pmid10635613">{{cite journal| author=Roujeau JC| title=Treatment of severe drug eruptions. | journal=J Dermatol | year= 1999 | volume= 26 | issue= 11 | pages= 718-22 | pmid=10635613 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10635613  }} </ref>
Line 30: Line 30:


==Other Pharmacologic Agents==
==Other Pharmacologic Agents==
Other pharmacologic agents that have been used in DRESS syndrome are the following:
Other pharmacologic agents that have been used in the management of DRESS syndrome are the following:
*[[Cyclosporin]]
*[[Cyclosporin]]
*[[Intravenous immunoglobulin]]
*[[Intravenous immunoglobulin]]

Revision as of 19:57, 21 September 2015

DRESS syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating DRESS syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

DRESS syndrome On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of DRESS syndrome

All Images
syndrome X-ray X-rays
syndrome Ultrasound Echo & Ultrasound
syndrome CT CT Images
syndrome MRI MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on DRESS syndrome

CDC on DRESS syndrome

DRESS syndrome in the news

Blogs on DRESS syndrome

Directions to Hospitals Treating DRESS syndrome

Risk calculators and risk factors for DRESS syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Medical Therapy

  • Drug withdrawal is the first step in the management of DRESS syndrome.
  • Patients with severe skin eruptions are usually admitted to the hospital for close monitoring and fluid/electrolyte management.
  • Supportive care is considered the mainstay of therapy, and administration of pharmacologic agents is usually necessary. Data from randomized clinical trials regarding the efficacy of immunosuppressive therapy in the management of DRESS syndrome is not yet available.
  • Persistent DRESS syndrome often requires prolonged therapy (possible beyond 1 year).
  • Patients hospitalized for DRESS syndrome require multidisciplinary care, including consultation by a dermatologist, hepatologist, and liver transplant specialist.
  • The following drugs have been used in the management of DRESS syndrome:

1. Symptomatic relief

  • Note: Avoid antipyretic drugs that are cleared by the liver (e.g. Acetaminophen) if liver injury is suspected and drugs cleared by the kidney (e.g. NSAIDs) if renal injury is suspected

2. Exfoliative dermatitis

  • Management of exfoliative dermatitis is similar to management of burns:[1]
  • Warming
  • Management of electrolyte derangements
  • Intake of high-caloric diet
  • Sepsis prevention

3. Liver involvement

  • Unknown benefit of systemic corticosteroids
  • Referral to liver transplant in cases of severe hepatic injury (> 3x ULN of LFTs)

4. Lung involvement

  • Systemic corticosteroids: Prednisone 0.5-2 mg/kg/day (or equivalent) IV until clinical improvement THEN tapered slowly over 2-3 months

5. Renal involvement

  • Systemic corticosteroids: Prednisone 0.5-2 mg/kg/day (or equivalent) IV until clinical improvement THEN tapered slowly over 2-3 months

Other Pharmacologic Agents

Other pharmacologic agents that have been used in the management of DRESS syndrome are the following:

References

  1. Roujeau JC (1999). "Treatment of severe drug eruptions". J Dermatol. 26 (11): 718–22. PMID 10635613.